← Back to guidelines
Dentistry3 papers

Leukoplakia of oral mucosa and tongue

Last edited:

Overview

Leukoplakia of the oral mucosa, particularly involving the tongue, is a common premalignant condition characterized by white patches that cannot be scraped off. These lesions often raise concerns due to their potential malignant transformation, especially in cases where they exhibit dysplasia or progress to squamous cell carcinoma (SCC). Understanding the nuances of diagnosis, staging, and management is crucial for optimizing patient outcomes. Recent studies have highlighted the importance of refining staging systems and surgical reconstruction techniques to improve both prognostic accuracy and functional outcomes post-treatment.

Diagnosis

Diagnosing leukoplakia, particularly when it involves the tongue, requires a thorough clinical examination and histopathological evaluation. Traditionally, the diagnosis hinges on the presence of persistent white patches that are not attributable to other causes such as infections or systemic conditions. However, the differentiation between benign leukoplakia and potentially malignant lesions necessitates careful assessment, often including biopsy for histopathological examination.

A recent study [PMID:39815672] proposes a modified staging system that incorporates critical factors such as base tongue involvement and whether the tumor crosses the midline. This refined approach has demonstrated superior prognostic value compared to conventional staging methods. Base tongue involvement and midline crossing are significant indicators of more aggressive disease, often correlating with poorer outcomes. Clinicians should therefore meticulously document these features during initial assessments to facilitate more accurate staging and prognostication. This modified staging system can guide tailored follow-up strategies and treatment planning, ensuring that patients with higher risk features receive appropriate surveillance and intervention.

Clinical Features and Differential Diagnosis

Clinically, leukoplakia presents as homogeneous white plaques that may be thick or thin, with varying degrees of surface texture. The differential diagnosis includes other white lesions such as oral candidiasis, lichen planus, and frictional keratosis. Histopathological examination remains pivotal in ruling out dysplasia or malignancy. Biopsy samples should be evaluated for cellular atypia, nuclear pleomorphism, and architectural disarray, which are hallmarks of malignant transformation.

Management

The management of leukoplakia, especially when it progresses to SCC, involves a multidisciplinary approach focusing on surgical intervention, reconstruction, and adjuvant therapies as needed. The extent of surgical resection and subsequent reconstruction play critical roles in determining functional outcomes and quality of life.

Surgical Resection

For patients diagnosed with SCC arising from leukoplakia, surgical resection is often the primary treatment modality. The extent of resection is influenced by the size and location of the lesion. Studies [PMID:37839153] suggest that for smaller resections, encompassing 20% or less of the oral tongue, non-flap reconstruction methods can offer significant advantages in terms of swallowing efficiency and speech intelligibility. These techniques, such as secondary intention healing or use of absorbable materials, minimize complications and preserve function effectively.

Conversely, for larger defects, typically involving 40-50% of the oral tongue, flap reconstruction techniques may be more beneficial. These methods, including radial forearm free flaps or lingual flaps, provide better structural support and functional outcomes, particularly in restoring swallowing function which can be severely compromised in extensive resections [PMID:37839153]. The choice between flap and non-flap reconstruction should be individualized based on the extent of the defect, patient-specific factors, and surgeon expertise.

Reconstruction Techniques

  • Non-Flap Reconstruction: Suitable for smaller defects, this approach minimizes surgical complexity and reduces the risk of donor site morbidity.
  • Flap Reconstruction: Indicated for larger defects, offering superior structural integrity and functional outcomes but with increased surgical complexity.
  • Adjuvant Therapies

    Adjuvant therapies, including radiation and chemotherapy, may be considered based on the stage and risk factors identified during staging. High-risk features such as base tongue involvement, depth of invasion (DOI) > 20mm, and midline crossing significantly influence the decision for adjuvant treatments [PMID:39815672].

    Prognosis & Follow-Up

    Prognostic factors play a crucial role in guiding treatment decisions and follow-up strategies for patients with oral tongue SCC arising from leukoplakia. A retrospective analysis of 398 cases [PMID:39815672] identified base tongue involvement, DOI > 20mm, and tumor crossing the midline as significant predictors of poorer disease-specific survival (DSS). These findings underscore the importance of meticulous staging to identify high-risk patients who may benefit from more aggressive management and closer surveillance.

    Follow-Up Recommendations

  • Regular Monitoring: Patients should undergo regular clinical examinations and imaging studies to monitor for recurrence or secondary malignancies.
  • Periodic Biopsies: Given the premalignant nature of leukoplakia, periodic biopsies may be warranted, especially in high-risk areas.
  • Quality of Life Assessments: Functional outcomes, including swallowing and speech, should be regularly assessed to guide further reconstructive interventions if necessary.
  • Future Research Directions

    While current evidence supports the integration of local extent factors into clinical staging for better treatment decisions, further prospective studies are needed to definitively establish when flap reconstruction significantly enhances functional outcomes post-oral tongue cancer resection [PMID:37839153]. These studies should control for variables such as extent of resection and specific subsites to provide clearer guidelines for clinical practice.

    Key Recommendations

  • Refined Staging: Utilize a modified staging system that includes base tongue involvement and midline crossing to improve prognostic accuracy.
  • Surgical Approach: Tailor surgical resection and reconstruction based on the extent of the lesion, favoring non-flap methods for smaller defects and flap techniques for larger defects.
  • Prognostic Factors: Focus on high-risk features such as DOI and tumor location to guide adjuvant therapy decisions and follow-up intensity.
  • Continuous Monitoring: Implement rigorous follow-up protocols to monitor for recurrence and functional outcomes, incorporating periodic biopsies and quality of life assessments.
  • By adhering to these recommendations, clinicians can enhance patient outcomes and manage the complexities associated with leukoplakia and its malignant transformations effectively.

    References

    1 Singh AG, Sinha S, Shetty R, Joshi P, Nair SV, Chaturvedi P. Impact of Local Extent of Tumor on the Survival Outcomes for Surgically Treated Tongue Cancers. Head & neck 2025. link 2 Cortina LE, Moverman DJ, Zhao Y, Goss D, Zenga J, Puram SV et al.. Functional considerations between flap and non-flap reconstruction in oral tongue cancer: A systematic review. Oral oncology 2023. link

    2 papers cited of 3 indexed.

    Original source

    1. [1]
      Impact of Local Extent of Tumor on the Survival Outcomes for Surgically Treated Tongue Cancers.Singh AG, Sinha S, Shetty R, Joshi P, Nair SV, Chaturvedi P Head & neck (2025)
    2. [2]
      Functional considerations between flap and non-flap reconstruction in oral tongue cancer: A systematic review.Cortina LE, Moverman DJ, Zhao Y, Goss D, Zenga J, Puram SV et al. Oral oncology (2023)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG